Savannah Therapeutics, Inc filed a Form D with the Securities and Exchange Commission on 2026-09-11.
Savannah Therapeutics, Inc filed a Form D notice of an exempt securities offering with the SEC on September 11, 2026. The filing reports $3.85M sold. Its industry group is Other Health Care. It names Thomas Wollan (Executive Officer), Matthew Dowling (Director) (SEC Form D, September 11, 2026).
Sell to companies like Savannah Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Savannah Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Savannah Therapeutics, Inc, from the filings we hold.
Other Health Care raises by companies based in Maryland, filed in September 2026, largest first.
Get an email when Savannah Therapeutics, Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Savannah Therapeutics, Inc raises, hires or launches. No email unless you switch it on.
Watch Savannah Therapeutics, Inc →Get the full cited report on Savannah Therapeutics, Inc
What the filing shows about Savannah Therapeutics, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Savannah Therapeutics, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Savannah Therapeutics, Inc See pricing
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $3.85M, on the same scale — one filing against the whole group's total, so it sits low by construction.
By form type: D ×1.
| Form | Filed | On EDGAR |
|---|---|---|
| D | 2026-09-11 | open |
What the filing shows about Savannah Therapeutics, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Savannah Therapeutics, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Savannah Therapeutics, Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
This is the only filing on record for this issuer, so there is no history to read yet. Incorporated in DE. Full history on sec.gov.
Thomas Wollan is named as Executive Officer on the Form D that Savannah Therapeutics, Inc filed with the SEC on 11 September 2026, one of 2 people that filing names.
Matthew Dowling is named as Director on the Form D that Savannah Therapeutics, Inc filed with the SEC on 11 September 2026, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2026-09-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Savannah Therapeutics, IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Savannah Therapeutics, Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Savannah Therapeutics, Inc. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-09-07 · Health care raises, week of 2026-09-07
https://mentionfox.com/funding/savannah-therapeutics-inc-form-d-000001